For those new, the following is extremely heavy on the

New Post Public Reply Private Reply Replies (1) Message Board
petemantx
1,104
For those new, the following is extremely heavy on the sarcasm.

The last few weeks seems to have proven what so many on this board keep trying to tell us, there is absolutely no nefarious doings being played by outsiders (whether MMs, hedge funds, cabals, major trading groups, whomever)against IPIX. There are very few shorts and for certain no naked shorts (of course, if there were wouldn't the "naked" mean they couldn't be traced?). What we have is a perfectly trading market adhering to all the rules put in place by the SEC. If any of the named bodies above were fiddling with the trading, we certainly would be protected by FINRA who would throw the top management of firms doing such brazen thievery in jail (or more likely give them a a token slap on the wrist, tell them not to do it again, and let them keep about 95% or more of the money they filched from honest investors with their illegal dealings.

Now how can I support such belief in the system such that it must have been bad company news that sent the stock price dropping? See the following:

1- B found to be one of only a handful of drugs found to be lethal to CV19 via computerized model of over 11K drugs.
2- Further testing by a govt lab showed B exceptionally effective in killing CV in a petri dish.
3- Further testing showed B killed 85% of CV19 within an hour against an extremely tough strain of CV19 in human kidney tissue
4- Further testing showed B killed 97% of CV19 in human lung tissue.
5- RBL that did the lab work on the human lung tissue (and had worked with B since 2018 against antifungals was so impressed with the results that they co-authored a grant request to do a PAN-CORONA investigation of B.
6- Both RBLs plan on publishing peer review articles of the work and findings they did on B because the results were so stellar.
7- Further testing at RBL showed at the lowest dose given to date B still showed a 90% effective kill rate of CV19 whereas Remsdesivir only showed a 50% kill rate. Thus, the SI (selectivity index), which is a great aid in determining those drugs with the highest expected success rate against CV19 and the safest, should be MUCH higher for B compared to Rems....
8- Testing results listed above shows that Brilacidin should kick Rems.... ass in a head to head trial.
9- Govt has already committed to a $2B order for Rems.... product. What would they commit to a product that wipes out Rems...?
10- Grant request was submitted in early July and keeps getting closer and closer to being announced.
11- B's 3 MOAs against CV19 gives it a Billion X Billion greater chance of viruses not being able to develop a resistance to it compared to all other drugs that have only a single MOA to kill CV19.
12- B's 3-in-1 properties of being antibacterial, anti-inflammatory, antiviral, and having strong immunotherapeutic properties makes it able to attack the results of the CV19 such as lung cell death, brain swelling, kidney disruption, bowel disruption, cytokine storm, etc while most every other drug just is able to try and kill the virus to a far, far less greater effect than B.
13- B does not alter the DNA of the human genome. Most other major drugs being discussed, especially for developing a virus, affect the DNA in a recombinant or like manner and to date NO DRUG HAS EVER BEEN tested to see what the long term effects on humans is of these drugs. But then, who doesn't mind for-profit companies playing with the human genome?

I think the above has pretty much made my point. Why wouldn't all stock holders have realized the price would plummet of our shares when we have been faced with the above body of news? Who would ever have thought such mind boggling success after success for B against CV wouldn't have set BIG MEDICINE on its ear (or maybe that is one of the problems, BIG MEDICINE realizes what a threat Brilacidin brings to SO MANY of their drugs which don't cure anything, just treats conditions for life long needed therapies off of which they happen to make a fortune? Who wouldn't have expected a major drop almost daily at the last second and a major drop right out of the gate in the first 15 minutes of trading by the MMs?

Yes, I now realize I should pity all us dumb long stock holders for the rose-colored glasses we have been wearing. Even a fool could look at the data above and see we were headed in an ever increasing spiral down in share price.

And if you believe that, you are most likely profiting from this unconscionable attack on IPIX. Not blaming the traders that buy and sell daily, that is all part of the game. But the larger game is being allowed by the regulatory bodies IMO and though they know how to fix the system the big money says to keep their hands off - and so they do.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyperscale Recalibrates: AI Boom or Risky Bet?

Updated Category News Views 0

Is Hyperscale Making the Right Move? Hyperscale Data, Inc. waved goodbye to the Bitcoin mining days to clear the stage for artificial intelligence (AI). But is this strategic leap off the blockchain and into AI territory as golden as promised? Whisper around the street is it could turn into a $3 billion windfall. But let's chew through the details before toasting...

Continue Reading
ADA Audit Reveals Gaps in Event Management at 2026 Session

Updated Category News Views 2

Hold onto your hats, folks, because the American Diabetes Association (ADA) just dropped a bombshell report with findings that'll make your head spin if you're keyed into the healthcare sector. They’ve wrapped this up in a bow of accountability, but let's dig into the crux of it. Behind the Controversy: The New Orleans Incident This all harks back to an incident on June...

Continue Reading
Corner Bakery Cafe Unveils Fall Treat Lineup

Updated Category News Views 3

Get Ready for a Fall Feast at Corner Bakery Cafe Pumpkin spice season is here, whether you're thrilled or grumbling about it. Corner Bakery Cafe is throwing its hat in the seasonal ring, bringing back its crowd-pleaser Pumpkin Latte—available hot, iced, or as a cold brew. They're also rolling out a lineup full of tempting treats aimed to capture those autumn cravings....

Continue Reading
3D Cloud Expands with Enhanced Visual CPQ Capabilities

Updated Category News Views 2

Changing the Game in Complex Product Configuration It's a new dawn in how customers tinker with custom products. Talk about blasting through the old convolutions of configuration. 3D Cloud's fresh offering makes product configuration a breeze, very much like choosing ingredients for a custom sandwich and seeing it come to life. Frankly, the introduction of 3D Visual CPQ...

Continue Reading
BKF Welcomes Andrew Esposito as New CFO

Updated Category News Views 5

BKF's Strategic Move: Andrew Esposito Steps In Don't walk past a headline like this without feeling the pulse of BKF's ambitious strides in the AEC industry. BKF, a heavyweight in the architecture, engineering, and construction sector, has tapped Andrew Esposito as its new Chief Financial Officer. Based out in sunny Oakland, California, they're looking to crank up their...

Continue Reading
American Tungsten's Bold Play in Nevada is Noteworthy

Updated Category News Views 10

American Tungsten's Shifting Focus Today we're chewing over some intriguing moves from American Tungsten & Antimony, Ltd. (ASX: AT4; OTCQX: ATALF). These cats are eyeing a chunk of the strategic metals market. They've engaged Metso Finland Oy to whip up a Scoping Study for an ammonium paratungstate (APT) production circuit at their Del Sol Refinery in Nevada. Why Tungsten...

Continue Reading
Trua Embarks on New Senior Support Journey in GA

Updated Category News Views 2

A New Chapter for Senior Care in South Fulton Here's a story that's probably tugging a few heartstrings: Trua Senior Living Locators has kicked off operations in South Fulton. This isn't just another business launch; it's a tale deeply rooted in personal experience. The man at the helm, Fred Giahi, knows firsthand the trials and tribulations families face when dealing...

Continue Reading
Charter CFO to Speak at Citi TMT Conference 2026

Updated Category News Views 9

Charting Charter's Future Moves at the Citi TMT Conference There's something electric about a company like Charter Communications showing up at a big-deal event like the Citi Global TMT Conference. It's not just another day in the office when Jessica Fischer, the Chief Financial Officer, steps up to the mic on September 10, 2026. Investors better have their ears perked...

Continue Reading
BD&J Shines in Elite 2026 Legal Ranking for California

Updated Category News Views 2

A Rare Nod from Chambers and Partners Now and then, the legal spotlight lands in places you don't quite expect. This time, it’s BD&J—a stalwart of the personal injury field—grabbing the limelight right from under the noses of California's Big Law giants. This firm has been pegged as a top contender in the 2026 Chambers and Partners Spotlight Guide. And let me tell...

Continue Reading
Nozomi Networks: Leading OT Security in 2026

Updated Category News Views 6

One Year of Massive Wins for Nozomi Networks Here's a wild trajectory: Nozomi Networks has been firing on all cylinders in 2026, capturing attention not just from analysts but also from anyone with a stake in the security game. The company’s impressive run was highlighted most recently when they were crowned a Leader in The Forrester Wave: Operational Technology...

Continue Reading

Top 5 Most Recently Viewed Articles

Valneva Updates IXCHIQ® Vaccine Guidelines for Seniors Age 65+

Updated Category News Views 152

Valneva Updates IXCHIQ® Vaccine Guidelines for Seniors Age 65+ Valneva SE (NASDAQ: VALN; Euronext Paris: VLA), a renowned specialty vaccine company, has made significant strides in its ongoing commitment to public health. As of now, the European Medicines Agency (EMA) has initiated a review of the chikungunya vaccine, IXCHIQ®, after receiving reports concerning adverse...

Continue Reading
Discover the Inspiring Journey of ''Sunshine in My Heart''

Updated Category News Views 109

Introducing ''Sunshine in My Heart'' Xulon Press proudly presents the first volume of My Sun & Shade book series, an empowering narrative aimed at women, chronicling profound moments of personal growth and spiritual enlightenment. A Journey of Faith and Resilience Written by Angela M. Viola, this memoir invites readers into a deeply personal story that unfolds the themes...

Continue Reading
Soma Gold Expands Operations with Escondida Mine Acquisition

Updated Category News Views 294

Soma Gold Announces New Mine Acquisition Soma Gold Corp. (TSXV: SOMA) has just made headlines with its latest decision to acquire the Escondida Mine, a significant move that could greatly impact its growth and production capabilities in the gold mining sector. Key Acquisition Details The Escondida Mine stretches over 1,051 hectares, fully permitted and poised for rapid...

Continue Reading
Artera Showcases Innovative Solutions for Healthcare Engagement

Updated Category News Views 176

Artera Unveils New Product Offerings at Heartbeat Conference In a groundbreaking event, Artera, a leading SaaS digital health innovator, recently showcased its latest product offerings aimed at revolutionizing patient interactions. This significant reveal took place during the vibrant Artera Heartbeat Customer Conference, which brought together over 300 health system...

Continue Reading
Investors of Tandem Diabetes Care Should Review Potential Claims

Updated Category News Views 218

Understanding the Situation with Tandem Diabetes Care, Inc. Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is currently under scrutiny concerning potential securities claims. Investors have reason to be vigilant as their rights might be affected by recent developments within the company. What is Being Investigated? The Rosen Law Firm, a reputable global investor rights law...

Continue Reading